Abstract
Glucocorticoids (GCs) have profound effects on development, metabolism, fluid and electrolyte balance, the stress response, and immune functions. GCs are effective antileukemic agents and kill T-lymphoid cells by inducing classical apoptosis [1] . GCs modulate their actions via binding to specific cytoplasmic GC receptors (GR), which translocate to the nucleus and regulate transcription of target genes [2] . GC-mediated gene regulation is a critical early aspect of GC-evoked apoptosis, and GCs have been shown to up or downregulate distinct sets of genes to evoke T-cell apoptosis [3, 4] . As is evident from microarray analysis, rather than a single gene, a network of coordinately regulated genes influences apoptosis [5, 6] . Such coordinate changes in gene expression may be facilitated by one or a few regulatory transcription factors.
Microarray analysis of GC-sensitive and -resistant human leukemic lymphoblastoid CEM cells has identified E4BP4 as a gene that is upregulated in response to GCs only in cells susceptible to GC-evoked apoptosis [7] . E4BP4 is a member of the basic region/leucine zipper (bZIP) containing family of transcription factors and shares DNA binding specificities with factors such as c-Jun and CREB [8] . E4BP4 binds to and represses transcription from the consensus sequence of (G/A)T (G/T)A(C/T)GTAA(C/T), unlike other bZIP family proteins, which activate gene transcription [9] . E4BP4 has been suggested to mediate GC-dependent gene repression, an essential contributor of GC-evoked apoptosis [10] . In murine osteoblasts, parathyroid hormone-dependent transcriptional downregulation was shown to be modulated by E4BP4 induction [11] . E4BP4 belongs to a highly conserved family of proteins involved in programmed cell death/cell proliferation [12] . Genes closely related to mammalian E4BP4 include genes 8 & 9 of Xaenopus laevis, ces-2 of Caenorhabditis elegans, and vrille of Drosophila melanogaster, all of which are involved in pro-apoptotic events such as tail resorption, neuronal cell death, and activation of pro-apoptotic signaling molecules [13, 14] . In contrast to its evolutionarily conserved function as a promoter of cell death, E4BP4 has been suggested to protect growth factor-dependent B-lymphocytes from apoptosis caused by interleukin-3 deprivation [15] . E4BP4 has been shown to regulate motoneuron growth and survival during neuronal development [16] . Upregulation of E4BP4 expression is associated with growth repression and apoptosis in response to tumor suppressors such as phosphatase and tensin homolog (PTEN) [17] . Studies presented here suggest a pro-apoptotic role for E4BP4 in GC-evoked T-lymphoblastic cell death.
Increase in [Ca 2+ ] i is an early and essential event during T and B cell activation, and is accompanied by regulation of transcription factors and alterations in gene expression that eventually modulate immune function, cell proliferation, differentiation, and death [18] . In thymocytes and T-lymphoblastoid cells, an increase in intracellular calcium ([Ca 2+ ] i ) levels represents an early biochemical change linked to GC-evoked apoptosis [19] . A correlation between elevation of [Ca 2+ ] i and apoptosis has been reported in human leukemic CEM cells [20] . Several mechanisms for calcium-dependent apoptosis have been proposed, including activation of specific Ca 2+ -dependent nucleases, calmodulin (CaM)-mediated activation of calcineurin, and transcriptional changes. In rat vascular smooth muscle cells, an increase in [Ca 2+ ] i upregulates E4BP4 expression [21] . Calcium chelation or specific inhibition of calcium signaling suggests that calcium plays an important role in regulating E4BP4 expression. Since GC-mediated gene repression and increases in [Ca 2+ ] i levels are both critical for GC-evoked apoptosis, we hypothesized that GC-evoked induction of [Ca 2+ ] i may upregulate E4BP4 expression and concomitantly activate apoptosis. Data presented here support this hypothesis.
Materials and methods
Reagents. Dexamethasone (Dex), ethylene glycol tetraacetic acid (EGTA), 2-bis(2-aminophenoxy)-ethane-N,N,N 1 ,N 1 -tetraacetic acid-acetoxymethyl (BAPTA), and thapsigargin (TG) were purchased from EMD Biosciences (Madison, WI). Reagents for RT-PCR, including M-MLV reverse transcriptase, oligo(dT) 15 primer, RNasin Ò Ribonuclease inhibitor, dNTP mix, and Taq DNA polymerase were purchased from Promega Life Sciences (Madison, WI). Calcium Greenä-1 AM, and propidium iodide were purchased from Molecular Probesä/Invitrogen (Carlsbad, CA). Other reagent grade chemicals were purchased from Fisher Scientific (Pittsburgh, PA) or Sigma Chemical Co. (St. Louis, MO).
Cell culture. Tissue culture media and components, including fetal bovine serum (FBS) were purchased from Mediatech (Washington, DC). CEM-C7-14 and CEM-C1-15 cells were kindly provided by Dr. E.B. Thompson (UTMB, Galveston, TX), and have been derived from the parental line CCRF-CEM, obtained from a patient with acute lymphoblastic leukemia [22] . Cells were cultured in RPMI 1640 medium supplemented with 5% FBS at 37°C in a humidified 5% CO 2 incubator, and were maintained in log phase by passaging every 3 days.
Measurement of cell viability. All treatment agents were prepared as 1000-fold concentrated stock solutions in ethanol. The final concentration of ethanol did not exceed 0.1% in any experiment, and appropriate controls with ethanol alone were run in parallel. Cells were plated at a density of 1 · 10 5 cells/ml and treated with the appropriate agent for 96 h. Aliquots were removed at 24 h intervals for cell counts. Viable cells were counted by the trypan blue exclusion method using a hemocytometer.
[Ca 2+ ] i measurements. [Ca 2+ ] i levels were measured flow cytometrically [23] at the UCLA Flow Cytometry Core Facility. Cells were treated with the appropriate agents for 24-48 h, washed once in phosphate-buffered saline (PBS), and resuspended in 500 ll PBS. The fluorescent dye Calcium Greenä-1 AM (Molecular Probes Cat # C-3011) was added to a final concentration of 2 lM, and cells were incubated for a further 60 min in the CO 2 incubator. Five hundred microliters of PBS containing 5 lg/ml propidium iodide was subsequently added to each tube, and fluorescence was measured at 530 nm (Calcium Green) and 625 nm (propidium iodide) emission wavelengths using a Becton-Dickinson FACScan Analytical Flow Cytometer.
Evaluation of cell cycle distribution and apoptosis. Cells seeded at a density of 1 · 10 5 cells/ml were treated with 100 nM Dex in the presence or absence of appropriate calcium signaling modulators for 48-72 h. Approximately one million cells were harvested, lysed, and stained sequentially in low and high salt solutions containing propidium iodide to measure DNA content by flow cytometry. To measure apoptosis via TUNEL (terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-Xnick end labeling) assay, cells were fixed in 4% paraformaldehyde and processed according to the protocol accompanying the kit from Boehringer-Mannheim as described previously [24] . Samples were analyzed flow cytometrically using a FACScan, and the Cell Quest 1.2 software (Becton-Dickinson, Bedford, MA). Data analysis was done using WinMDI 2.8.
RT-PCR analysis. Cells were treated at a density of 4 · 10 5 cells/ml for 24 h with the appropriate agent. Approximately 1 · 10 7 cells were harvested, washed once with chilled PBS, and RNA was extracted using the TRIzol reagent (Invitrogen Life Technologies, La Jolla, CA). Five micrograms of total RNA was reverse transcribed at 42°C for 2 h in the presence of 0.5 lg oligo(dT) 15 
Results

Sensitivity to GCs
As described in the literature [7] , and shown in Figure 1 s of Supplementary Materials, the CEM sister clones CEM-C7-14 and CEM-C1-15 are sensitive and resistant, respectively, to GC-evoked apoptotic cell death.
Correlation of increase in [Ca 2+ ] i with apoptosis
Intracellular Ca 2+ levels were monitored flow cytometrically using the fluorescent dye Calcium Greenä-1 AM, a cell permeable dye, which upon binding to calcium, increases the intensity of fluorescence emission at 530 nm in proportion to the calcium concentration. Cells were simultaneously stained with propidium iodide, a dye that stains DNA if the membrane integrity is compromised, to monitor cell viability. As demonstrated in Fig. 1C , after a 48 h treatment of CEM-C7-14 cells with 100 nM of the synthetic GC dexamethasone (Dex), 38.1% cells were viable and had high calcium levels (lower right quadrant). In contrast, in CEM-C1-15 cells, Dex treatment for 48 h caused only 2.1% cells were found in the lower right quadrant (panel D). In agreement with the time course of their response to Dex, approximately 19.6% of CEM-C7-14 cells were non-viable and showed increased propidium iodide staining after 48 h (upper left quadrant). In contrast, only 4.4% of CEM-C1-15 cells had increased propidium iodide staining after 48 h in 100 nM Dex. Ethanol treatment did not significantly affect calcium levels or cell death in either cell type (panels A and B). As shown in Figure 2 The ability of Dex to regulate E4BP4 expression was tested using an RT-PCR assay (Fig. 2) . RNA extracted from CEM-C7-14 or CEM-C1-15 cells treated for 24 h with ethanol or 10 nM-1 lM Dex was reverse transcribed and E4BP4 or actin specific DNA was amplified by PCR
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Ethanol 100 nM Dex , washed, and resuspended at 1 · 10 6 cells/ml. The fluorescent dye Calcium Greenä-1 AM was added to cells to a final concentration of 2 lM, and cells were incubated at 37°C for one hour. Propidium iodide dye was added to a final concentration of 2.5 lg/ml to monitor cell viability. Cells were analyzed flow cytometrically for propidium iodide staining (625 nm) and for Calcium-Green fluorescence (530 nm), using a Becton-Dickinson FACScan Flow Cytometer and a WinMDI 2.8 software.
( Fig. 2A) . Dex upregulates E4BP4 expression in a dosedependent manner in CEM-C7-14 cells, while minimally upregulating expression in CEM-C1-15 cells. In CEM-C7-14 cells, 10 nM Dex was sufficient to evoke a 2-fold increase in E4BP4 expression over basal (ethanol treated) levels, while the same concentration failed to evoke a response in CEM-C1-15 cells. In CEM-C7-14 cells, 1 lM Dex evoked a 3.5-fold increase, while in CEM-C1-15 cells the increase was approximately 1.7-fold (Fig. 2B) .
Protection of CEM-C7-14 cells from GC-evoked apoptosis by calcium chelators
To test the hypothesis that increases in [Ca 2+ ] i mediate an increase in E4BP4 expression and subsequent apoptosis, the ability of intra-and extracellular calcium chelators to protect CEM-C7-14 cells from Dex-evoked cell death was evaluated. The intracellular calcium chelator 2-bis(2-aminophenoxy)-ethane-N,N,N 1 ,N 1 -tetraacetic acid-acetoxymethyl (BAPTA)-AM and the extracellular calcium chelator, ethylene glycol tetra acetic acid (EGTA) at concentrations above 10 lM BAPTA or 200 lM EGTA are toxic and compromise cell viability (data not shown). Lower concentrations of these chelators themselves have no effect on cell viability, but significantly protect CEM-C7-14 cells from cell death evoked by 100 nM Dex. Four days after treatment with 100 nM Dex cell viability had reduced to 8% of ethanol treated controls. In the presence of 1 lM BAPTA or 20 lM EGTA, the Dex-evoked death was reduced, with viable cell numbers being 23% and 28% of ethanol treated or BAPTA or EGTA alone treated controls (Fig. 3A) ] i levels, respectively (in the lower right quadrant). In the presence of 20 lM EGTA, these numbers were reduced to 2%, 12.4%, and 23.1% respectively (panels D-F). Similar results were obtained for BAPTA (data not shown).
Sensitization of CEM-C1-15 cells to GC-evoked apoptosis by the calcium ionophore A23187
Since the resistance of CEM-C1-15 to Dex correlates with an inability to induce [Ca 2+ ] i levels, the effect of elevating [Ca 2+ ] i on cell viability was tested. Neither 100 nM Dex nor 150 nM A23187 significantly affected cell viability. However, combined treatment with Dex and A23187 reduced viable cell number to 14% of individual treatments after 72 h (Fig. 3B) . These data confirm that the GC-resistance of CEM-C1-15 cells is at least partially caused by their inability to increase [Ca 2+ ] i levels. In CEM cells, apoptosis is preceded by G1 arrest and accumulation of cells with sub-G1 DNA content. To test the ability of 5 cells/ml with 0-1 lM Dex. Total RNA was extracted, using the TRIzol reagent. Reverse transcription (RT) using 5 lg total RNA was performed at 42°C using the MMLV reverse transcriptase, dNTP mix, RNase inhibitor, and oligo(dT) 15 as a primer. Two microliters of the RT product was subjected to 25 cycles of PCR using the E4BP4 or actin-specific primers indicated in the methods section, to amplify a 606 bp fragment for E4BP4 or a 914 bp fragment for actin. PCR products (10 ll E4BP4, 2 ll actin) from variously treated samples were resolved on a 1% Agarose gel along side a 100 bp DNA ladder. (B) Ethidium bromide stained bands from (A) were densitometrically scanned for band intensity using the ImageJ software, and ratios of E4BP4 to actin band intensities were obtained. Data are represented as fold-change in ratios over ethanol treated controls (0 nM Dex).
A23187 to sensitize CEM-C1-15 cells to GC-evoked apoptosis, cells treated with ethanol alone, 100 nM Dex, 150 nM A23187, or both agents together were stained with propidium iodide and subjected to cell cycle analysis by flow cytometry (Figure 3 s , Supplementary Material) . After 48 h of treatment, 1.4%, 2%, and 8.8% of cells treated with ethanol, 100 nM Dex, and 150 nM A23187 respectively, had a sub-G1 DNA content. Combined treatment with 100 nM Dex and 150 nM A23187 caused 32% of cells to accumulate in sub G1, suggesting an apoptotic mechanism of cell death.
Modulation of E4BP4 expression by manipulating [Ca 2+ ] i levels
To determine whether E4BP4 expression is dependent on [Ca 2+ ] i levels, CEM-C7-14 cells were treated with ethanol or 100 nM Dex in the absence or presence of either 1 lM BAPTA or 20 lM EGTA for 24 h. Total RNA was extracted and subjected to RT-PCR analysis to determine the effect of calcium chelation on E4BP4 expression. Both BAPTA and EGTA abolished Dex-evoked upregulation of E4BP4 expression (Fig. 5A) , although BAPTA alone evoked a 1.5-fold induction of E4BP4 expression. To determine whether the failure of Dex to upregulate E4BP4 expression in CEM-C1-15 cells was related to the inability of Dex to induce [Ca 2+ ] i levels, CEM-C1-15 cells were treated with Dex in the presence or absence of the calcium ionophore A23187 to raise [Ca 2+ ] i levels. Either Dex or A23187 failed to significantly upregulate E4BP4 expression, however, when combined, these two agents synergistically up regulated E4BP4 expression (Fig. 5B) , confirming our hypothesis that GC-mediated induction of E4BP4 expression is modulated via increases in [Ca 2+ ] i levels. Our data support the idea that increases in [Ca 2+ ] i levels may not be sufficient to evoke E4BP4 upregulation but may be necessary to facilitate the GC-evoked cell death.
Effect of thapsigargin on [Ca 2+ ] i levels and E4BP4 expression in CEM cells
Thapsigargin (TG) is a cell permeable sesquiterpene lactone that releases calcium into the cytoplasmic compartment by inhibiting endoplasmic reticular Ca 2+ -ATPase [25] . It has been shown to induce apoptosis in rat thymocytes [25] . To determine the ability of TG to increase ] i levels, however, a majority of the CEM-C7-14 cell population was dead (data not shown).
E4BP4 expression was upregulated in a dose-dependent manner in response to TG in both CEM-C7-14 and RNA was extracted and 5 lg total RNA was used in a reverse transcription reaction, and subsequent PCR to amplify fragments specific for E4BP4 or actin, as described for Fig. 4 . Ratios on E4BP4 to actin band intensities were normalized to ethanol control values to obtain fold-change and are plotted in the lower panel. (B) CEM-C1-15 cells at a density of 4 · 10 5 cells/ml were treated for 24 h with ethanol, 150 nM A23187, 100 nM Dex or both. RNA was extracted and subjected to RT-PCR to amplify fragments specific for E4BP4 or actin, as described for (A). Fold-change in E4BP4 expression was calculated as in (A) and is plotted in the lower panel.
CEM-C1-15 cells, however, the effect was much more pronounced in CEM-C7-14 cells (Fig. 6E) , with almost 2-fold induction at all concentrations of TG. CEM-C1-15 cells showed only a 1.25-fold increase up to 200 nM TG, and 1.6-fold induction at 1 lM TG. These data correlate with the cell viability and [Ca 2+ ] i levels of the two sister clones in response to TG (Figs. 6A-D) , which was also more pronounced in CEM-C7-14 cells. These data confirm our hypothesis that increases in [Ca 2+ ] i levels upregulate E4BP4 expression and contribute to CEM cell apoptosis.
Discussion
GC-evoked T-lymphocyte apoptosis has been studied extensively, yet the molecular pathway remains unclear. The process requires de novo RNA and protein synthesis, suggesting that gene regulatory changes are crucial for apoptosis induction [26] . GCs regulate a wide array of genes, reflecting their diverse actions on cell physiology. Because of the pleotropic effects of GCs, it has been difficult to correlate GC-evoked apoptosis with specific gene regulatory changes. Studies on individual genes, or microarray analyses have implicated regulatory changes in several genes in GC-evoked T-lymphocyte apoptosis, including downregulation of c-myc, cyclin D3, ornithine decarboxylase (odc), and upregulation of GR, c-jun, dexamethasone-induced gene 2(dig2), FK506 binding protein 51 (FKBP5), Down Syndrome Critical Region 1 (DSCR1), Bim, etc [27] [28] [29] . These data suggest that a network of genes, rather than one or a few genes, coordinately regulates apoptosis.
Among the list of genes upregulated in only those CEM cell clones that are susceptible to GC-evoked apoptosis, but not in a CEM clone non-responsive to GCs, is the gene for adenoviral E4 binding protein 4 (E4BP4) [7] , an evolutionarily conserved transcriptional repressor belonging to the bZIP family of transcription factors [9] . GR-evoked transcriptional repression has been shown to be important for GC-evoked apoptosis [30] . GC-mediated E4BP4 upregulation has been suggested as a mechanism of gene repression by GCs in murine fibroblasts [10] . Indeed, as demonstrated here, GCs upregulate E4BP4 in human T-lymphoblastic leukemia cells, in correlation with apoptosis. In the two human leukemic CEM sister clones studied here, the synthetic GC Dex upregulated E4BP4 in a dose-dependent manner in only the clone (CEM-C7-14) that was susceptible to Dex-evoked apoptosis. Hence, GC-mediated E4BP4 upregulation may be a key early event that triggers subsequent transcriptional changes, including gene repression, driving a cell towards apoptosis.
Another signature change preceding apoptosis of T-lymphocytes and leukemic T cells is the increase in [Ca 2+ ] i levels [31, 32] . It has been proposed that calcium levels regulate the extent of apoptosis via various mechanisms, including activation of calcium-dependent endonucleases . Cells were harvested, RNA was extracted and subjected to RT-PCR for E4BP4 and actin as described in Fig. 4 . PCR products were resolved on a 1% agarose gel as in Fig. 4 . Ethidium bromide stained bands from the gel were densitometrically scanned for band intensity using the ImageJ software, and ratios of E4BP4 to actin band intensities were plotted in the lower panel. Data are represented as fold-change in ratios over ethanol treated controls (0 nM TG).
and activation of the calcium signaling pathway [19, 33, 34] E4BP4 expression is upregulated in a calcium-dependent manner in rat aortic smooth muscle cells. In this model, inhibition of calcium signaling abrogated calcium-dependent E4BP4 upregulation [21] . In studies described here, GC-mediated E4BP4 upregulation was also shown to be calcium-dependent, and was inhibited by calcium chelators. Data presented here suggest a cause-and-effect relationship between GC-evoked increases in [Ca 2+ ] i levels, E4BP4 upregulation, and CEM cell apoptosis. GC-independent increases in [Ca 2+ ] i levels by TG correlated with E4BP4 upregulation and cell death in CEM-C7-14 cells. It was interesting to note that CEM-C1-15 cells were more resistant to TG-evoked increases in [Ca 2+ ] i levels, E4BP4 upregulation, and cell death when compared to CEM-C7-14 cells, just as has been observed for GC-evoked responses. These results suggest a downstream common pathway between GC and TG to evoke cellular changes resulting in apoptosis.
Within the bZIP family of transcription factors, E4BP4 is closest in homology to those containing a PAR (proline and acidic residue rich) domain, although E4BP4 lacks a PAR domain [8, 12] . Notably, while PAR containing bZIP factors activate transcription, E4BP4 represses transcription [12] . Other homologous PAR domain lacking bZIP genes include the C. elegans ces-2 (cell death selector) gene, which promotes neuronal cell death, the Drosophila vrille gene, which induces apoptosis in embryonic dorsal epidermis, and genes 8 and 9 in X. laevis, which contribute to tail resorption [13, 14] . Based on these homologous genes, one might expect E4BP4 to be pro-apoptotic; however, depending of the cell type and downstream effectors, E4BP4 has been shown to promote cell survival [15, 16] , induce apoptosis [17] , or promote parathyroid hormone-mediated catabolism in osteoblasts [11] . In human B-lymphocytes, E4BP4 is upregulated by IL-3 (hence the alternative name: Nuclear factor regulated by IL3; NFIL3) and promotes survival of IL-3-dependent cells [15] . Similarly, in rat motoneurons, E4BP4 serves as a survival factor, and is expressed at high levels in those neurons that escape natural apoptosis [16] . Interestingly, the C. elegans CES-2 blocks the activity of a survival factor, CES-1, to evoke an apoptotic response [13] . The vertebrate homolog of CES-1, Slug, is upregulated in leukemic B-lymphoblasts by the chimeric oncoprotein, E2A-HLF, which binds to the same consensus sequence as, and is proposed to act similarly to E4BP4 [35] . These data reveal the opposing effects that ces-2 or E4BP4 have on the downstream survival factors ces-1 or Slug, respectively. E4BP4 actively antagonized the ability of IL-6 to rescue these cells from p53-induced apoptosis, suggesting that E4BP4 was a pro-apoptotic factor [36] . E4BP4 is ubiquitously expressed, however, its expression is shown to be minimal in tumors and transformed cell lines [17] . Upregulation of E4BP4 expression is associated with growth repression and apoptosis in response to tumor suppressors such as phosphatase and tensin homolog (PTEN) [17] .
E4BP4 is often referred to in the literature as a survival gene, owing to its role in survival of IL-3-dependent B-lymphocytes. However, it is clear that E4BP4 acts as a pro-apoptotic factor in cancer cells and its upregulation is associated with promotion of apoptosis in some systems.
